- Home
- JAGX vs OKTA Comparison
JAGX vs OKTA Comparison
Compare JAGX & OKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- OKTA
- Stock Information
- Founded
- JAGX 2013
- OKTA 2009
- Country
- JAGX United States
- OKTA United States
- Employees
- JAGX 49
- OKTA N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- OKTA Computer Software: Prepackaged Software
- Sector
- JAGX Health Care
- OKTA Technology
- Exchange
- JAGX Nasdaq
- OKTA Nasdaq
- Market Cap
- JAGX 3.1M
- OKTA N/A
- IPO Year
- JAGX N/A
- OKTA 2017
- Fundamental
- Price
- JAGX $4.85
- OKTA $104.63
- Analyst Decision
- JAGX
- OKTA Buy
- Analyst Count
- JAGX 0
- OKTA 35
- Target Price
- JAGX N/A
- OKTA $114.97
- AVG Volume (30 Days)
- JAGX 37.8K
- OKTA 3.7M
- Earning Date
- JAGX 03-31-2025
- OKTA 05-28-2025
- Dividend Yield
- JAGX N/A
- OKTA N/A
- EPS Growth
- JAGX N/A
- OKTA N/A
- EPS
- JAGX N/A
- OKTA 0.15
- Revenue
- JAGX $11,689,000.00
- OKTA $2,610,000,000.00
- Revenue This Year
- JAGX $18.18
- OKTA $11.88
- Revenue Next Year
- JAGX $40.06
- OKTA $10.00
- P/E Ratio
- JAGX N/A
- OKTA $693.63
- Revenue Growth
- JAGX 19.75
- OKTA 15.33
- 52 Week Low
- JAGX $4.41
- OKTA $70.56
- 52 Week High
- JAGX $540.00
- OKTA $118.07
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- OKTA 46.27
- Support Level
- JAGX $4.41
- OKTA $102.91
- Resistance Level
- JAGX $5.45
- OKTA $118.07
- Average True Range (ATR)
- JAGX 0.95
- OKTA 3.65
- MACD
- JAGX 0.00
- OKTA -1.59
- Stochastic Oscillator
- JAGX 3.54
- OKTA 9.20
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.